References
- Condelli W, Fairbank J, Dennis M, et al. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subs Abuse Treat 1991; 8: 203–212
- Kosten T R, Rounsaville B J, Kleber H D. A 2.5 year follow‐up of cocaine use among treated opioid addicts: have our treatments helped?. Arch Gen Psychiatry 1987; 44: 281–284
- Kosten T R, Kleber H D, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 1989; 44: 887–892
- Kosten T R, Rounsaville B J, Kleber H D. Antecedents and consequences of cocaine abuse among opioid addicts: a 2.5 year follow‐up. J New Ment Dis 1988; 176: 176–181
- Kosten T A, Jacobsen L S, Kosten T R. Severity of precipitated opiate withdrawal predicts drug dependence by DSM‐III‐R criteria. Am J Drug Alcohol Abuse 1989; 15: 237–250
- Kosten T A. Cocaine attenuates the severity of naloxone‐precipitated opioid withdrawal. Life Sci 1990; 47: 1617–1623
- Kosten T R, Kleber H D, Morgan C. Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 1989; 26: 637–639
- Killian A K, hex K, Schuster C R. The effects of naloxone on behavior maintained by cocaine and heroin injection in the hesus monkey. Drug Alcohol Depend 1978; 3243–251
- Goldberg S R, Woods J H, Schuster C R. Nalorphine‐induced changes in morphine self‐administration in rhesus monkeys. J Pharmacol Exp Ther 1971; 176: 464–171
- Eaenberg A, Pettit H O, Bloom F E, et al. Heroin and cocaine intravenous self‐administration in rats: mediation by separate neural systems. Psychopharma‐col Ser 1982; 78: 204–209
- Carroll M E, Lac Walker M J, Sr., et al. Effects of naltrexone on intravenous cocaine self‐administration in rats during food satiation and deprivation. J Pharmacol Exp Ther 1986; 238: 1–7
- Hargraves W A. Methadone dosage and duration for maintenance treatment. Research on the Treatment of Narcotic Addiction: State of the Art, J R Cooper, E Altman, B S Brown, et al. National Institute on Drug Abuse, Rockville, MD 1983; 19–79
- Stitzer M L, McCaul M E, Bigelow G E, et al. Chronic opiate use during methadone detoxification: effects of a dose increase treatment. Drug Alcohol Depend 1984; 14: 37–44
- United States General Accounting Office. Methadone maintenance—some treatment programs are not effective: greater federal oversight needed. Publication GAO/HRD‐90–104, U.S. General Accounting Office, Washington, DC 1990
- Strain E C, Stitzer M L, Bigelow G E, et al. Methadone dosing level: effect on treatment outcome. Proceedings of the 53rd Committee for Problems in Drug Dependence annual meeting, NIDA Monogr 119. U.S. Government Printing Office, Washington, DC 1991; 357
- Higgins S T, Stitzer M L, Bigelow G E, et al. Contingent methadone delivery: effects on illicit opiate use. Drug Alcohol Depend 1986; 17: 311–322
- Newman R G, DesJarlais D C. Criteria for judging methadone maintenance programs. JAMA 1991; 265: 2190–2191
- Kirby K C, Stitzer M L, Brockish M. Contingency management aftercare for polydrug abuse in methadone maintenance patients. Proceedings of the 53rd Committee for Problems in Drug Dependence annual meefing, NIDA Monogr 119. U.S. Government Printing Office, Washington, DC 1991; 474
- Rhoades H, Ronith E, Kirky K, et al. Joint action of methadone dose and take home dose frequency in treatment compliance. Proceedings of the 52nd Committee for Problems in Drug Dependence annual meeting, NIDA Monogr 160. U.S. Government Printing Office, Washington, D.C. 1990; 453
- Chambers C D, Taylor W J R, Moffett A D. The incidence of cocaine abuse among methadone maintenance patients. Int J Addict 1972; 7: 427–441
- Black J L, Dolan M P, Penk W E, et al. The effect of increased cocaine use on drug treatment. Addict Behav 1987; 12: 289–292
- Magura S, Casriel C, Goldsmith D S, et al. Contingency contracting with polydrug‐abusing methadone patients. Addict Behav 1988; 13: 113–118
- Clarke M J. Cocaine and morphine withdrawal. Lancet 1989; 2: 381–382
- Freud S. Cocaine Papers, R Byck. Meridian, New York 1975; 69–72
- Finnegan L P, Mellott J M, Ryan L M, . Perinatal exposure to cocaine: human studies, in Cocaine Pharmacology. Physiology, and Clinical Stratepes, J M Lakoski, M T Galloway, F J White, et al. CRC Press, Boca Raton, FL 1991
- Hammer R P, Jr. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 1989; 3: 55–60
- Koob G F, Bloom F E. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715–723
- Hakan R L, Hendrikson S J. Opiate influences in nucleus accumbens neuronal electrophysiology: do‐pamine and nondopamine mechanisms. J Neurosci 1989; 9: 3538–3546
- Houdi A A, Bardo M T, VanLoon G R. Opioid mediation of cocaine‐induced hyperactivity and reinforcement. Brain Res 1989; 497: 195–198
- Wise R A. The neurobiology of craving: implication for the understanding and treatment of addiction. J Abnorm Psychol 1988; 97: 118–132
- Kreek M J, Garfield J W, Gutjahr C L, et al. Rifampin‐induced methadone withdrawal. N End J Med 1976; 294: 1104–1106
- Tong T G, Pond S M, Kreek M J, et al. Phenytoin‐induced methadone withdrawal. Ann Intern Med 1981; 94: 349–351
- Tennant F S, Jr. Inadequate plasma concentrations in some high‐dase methadone maintenance patients. Am J Psychiauy 1987; 144: 1349–1350
- Tusel D, Banys P, Sees K. The effect of rate of methadone metabolism on trearment outcome. Proceedings of the 52nd Committee for Problems in Drug Dependence annual meeting, NIDA Monogr 160. U.S. Government Printing Office, Washington, DC 1990; 454